There were 301 press releases posted in the last 24 hours and 437,828 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Certa Therapeutics presents positive data from a Phase 2 clinical study highlighting the potential benefit of FT011 as a novel treatment for scleroderma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image